#Vorasidenib
LightNews LightNews
oncodaily.bsky.social
Vorasidenib (Voranigo): What patients need to know?

oncodaily.com/drugs/vorasi...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Vorasidenib #Voranigo #Astrocytoma #BrainTumors #Drugs #FDAapprovals #Oligodendroglioma
Vorasidenib (Voranigo): What patients need to know? - OncoDaily
Learn about Vorasidenib (Voranigo), its uses in cancer, side effects, dosage, administration, and what should patients expect during treatment.
oncodaily.com
June 30, 2025 at 5:50 PM
jmwerner.bsky.social
🚨 Study by Galldiks et al. showing metabolic response to vorasidenib in IDH-mut gliomas using PET monitoring. This highlights FET PET’s potential to provide earlier & more informative assessments of treatment response than MRI in patients receiving IDH-inhibitors
academic.oup.com/noa/advance-...
Evaluation of early metabolic changes following vorasidenib using FET PET in patients with IDH-mutant gliomas
SUMMARY. The phase-3 INDIGO trial demonstrated that the IDH inhibitor vorasidenib significantly prolonged progression-free survival and delayed interventio
academic.oup.com
November 29, 2024 at 4:21 PM
oncodaily.bsky.social
Vorasidenib (Voranigo): Uses in Cancer, Side Effects, Dosage, Expectations, and More

oncodaily.com/drugs/vorasi...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Vorasidenib #Voranigo #Astrocytoma #BrainTumor #Drugs #FDAapprovals #Glioma #Oligodendroglioma
Vorasidenib (Voranigo): Uses in Cancer, Side Effects, Dosage, Expectations, and More - OncoDaily
Learn about Vorasidenib (voranigo), its uses in cancer treatment, side effects, dosage, and expectations. It is used for IDH mutated brain tumors.
oncodaily.com
June 29, 2025 at 10:02 PM
nejm.org
A recent study unpicks a key immune-mediated mechanism of mutant IDH–blocking drugs such as vorasidenib in the treatment of IDH-mutant glioma. Learn more in a new Clinical Implications of Basic Research article: nej.md/4f3dIMf

#MedSky
Heating Up IDH-Mutant Gliomas | NEJM
A recent study unpicks a key immune-mediated mechanism of mutant IDH–blocking drugs such as vorasidenib in the treatment of IDH-mutant glioma.
nej.md
December 11, 2024 at 5:09 PM
braintumourrsch.bsky.social
Vorasidenib and APPG News - Your voice matters!

🗣️ Share your experience of vorasidenib, email Hugh: hugh@braintumourresearch.org to have your voice heard at the 20th Nov appraisal.

Read more: https://bit.ly/4qhptoT

#TogetherWeWillFindACure #BrainTumourResearch #Vorasidenib
October 19, 2025 at 5:34 PM
cosynetherapeutics.bsky.social
This approval, however, leaves Vorasidenib inaccessible to patients in the rest of the UK and Ireland. We support Brain Cancer Justice in their call to the NHS and NICE to introduce vorasidenib into the clinic UK-wide.
March 10, 2026 at 2:31 PM
roelverhaak.bsky.social
As the year comes to a close, the biggest development in the brain cancer space was the FDA approval of vorasidenib for treatment of untreated low grade glioma. What was yours?
December 23, 2024 at 8:37 PM
agnolotti.bsky.social
2 years into recurrence. Apparently it's been 1 year since I started taking vorasidenib, one of the latest developments in treating brain cancer. DEFINITELY NOT CHEMO
May 14, 2026 at 3:02 PM
cri-utsw.bsky.social
ONLINE NOW in @science.org Translational Medicine from CRI's McBrayer Lab: www.science.org/doi/10.1126/.... Full 🧵 in comments ⬇️ #relentlessdiscovery 🧪
Vorasidenib improves response to subsequent chemoradiation in a genetically engineered mouse model of IDH-mutant glioma
A genetic mouse model of IDH-mutant glioma responds to mutant IDH inhibitor (mIDHi) and shows that prior mIDHi treatment improves response to chemoradiation.
www.science.org
August 5, 2026 at 6:05 PM
kleinergag.bsky.social
Mit mRNA gegen Krebs steht die Medizin vor einer wahren Revolution: Nachhaltige Heilung per Impfung.

Mich wundert, wie wenig darüber berichtet wird.

Vielleicht liegt es auch daran, dass klassische Krebsbehandlungen für „Big Pharma“ ein (bisher) sicheres Multimilliarden-Geschäft sind.
Vorasidenib: Eine Pille verlangsamt Hirntumore
Ein neues Medikament kann hinauszögern, dass Hirntumore weiter wachsen. In den USA ist es bereits zugelassen. Doch die Hoffnung hat ihren Preis.
www.zeit.de
September 23, 2024 at 9:05 AM
Financial toxicity in cancer meds: @portalresearch.org's collaborator @eddiecliff.bsky.social and others review the potential financial implications of receiving vorasidenib for glioma and how different countries manage the high cost: academic.oup.com/nop/advance-...
Financial challenges of being on long-term, high-cost medications
Abstract. The isocitrate dehydrogenase (IDH) inhibitor, vorasidenib, may offer a promising new treatment option for patients with IDH-mutant gliomas. Howev
academic.oup.com
December 10, 2024 at 2:37 PM
uk-charity.bsky.social
NICE's decision on Vorasidenib impacts brain tumour research funding. How can we advocate for better treatments? #BrainTumourAwareness

https://www.thebraintumourcharity.org/news/policy-news/help-shape-response-nice-decision-vorasidenib/
We need to hear from you: Help shape our response to NICE’s draft decision on vorasidenib
NICE has decided not to recommend vorasidenib for use on NHS. We need your help in turning their no into a yes. Find out how!
www.thebraintumourcharity.org
October 15, 2025 at 8:28 AM
andreberlinde.bsky.social
Inzwischen vermute ich Nebenwirkungen vom Medikament Vorasidenib.
Kann jemand bzw. falls wer Zeit hat mal nachgucken und einschätzen unter 4.8
www.google.com/url?sa=t&sou...

bsky.app/profile/andr...
October 21, 2025 at 6:13 AM
kerryjeanlister.bsky.social
Well this is good news. Have emailed my oncologist to see if I'm allowed to have it or not...

braintumourresearch.org/blogs/latest...
First new adult brain tumour treatment in 20 years approved
Vorasidenib has been approved to treat low-grade glioma brain tumours on the NHS in England and Wales. Read what this means for brain tumour patients.
braintumourresearch.org
March 31, 2026 at 4:57 PM
nmnsymposium.bsky.social
Early seizure freedom with [18F]fluorodopa positron emission tomography response after isocitrate dehydrogenase inhibition with vorasidenib: First case report.
onlinelibrary.wiley.com/doi/full/10....
Early seizure freedom with [18F]fluorodopa positron emission tomography response after isocitrate dehydrogenase inhibition with vorasidenib: First case report
Vorasidenib, a dual isocitrate dehydrogenase 1/2 (IDH1/2) inhibitor, showed superior efficacy in prolonging progression-free survival and time to next intervention in IDH-mutant grade 2 gliomas. This...
onlinelibrary.wiley.com
August 25, 2025 at 2:07 PM
kerryjeanlister.bsky.social
more info here: www.thebraintumourcharity.org/news/policy-...
We need to hear from you: Help shape our response to NICE’s draft decision on vorasidenib
NICE has decided not to recommend vorasidenib for use on NHS. We need your help in turning their no into a yes. Find out how!
www.thebraintumourcharity.org
October 16, 2025 at 9:27 AM
healthcareengage.bsky.social
The Scottish Medicines Consortium (SMC) has approved Vorasidenib for use by NHS Scotland to treat people aged 12 or older with IDH-mutated, low grade gliomas. Our CEO, Dr Micehele Afif, said "This is a moment of real celebration for the Scottish brain tumour community.
Click below for more.
Vorasidenib approved for use in Scotland
We’re delighted to share the news that vorasidenib has been approved by the Scottish Medicines Consortium to treat some low grade gliomas.
www.thebraintumourcharity.org
March 10, 2026 at 8:53 AM
clin-med.bsky.social
#hotoffthepress

In this #CME review, the authors report the pivotal results of the INDIGO clinical trial of vorasidenib versus placebo for patients with IDH mutant low-grade glioma ⬇️

www.sciencedirect.co...
September 24, 2026 at 9:00 AM
runningdoc.bsky.social
I just came across updated data on perioperative IDHi #vorasidenib and #ivosidenib in IDH1-mutated diffuse glioma presented at #SNO24. As someone who used to be heavily involved in early clinical development I am really delighted to see continuing progress. www.onclive.com/view/periope...
Perioperative Vorasidenib and Ivosidenib Remain Effective, Safe in IDH1+ Diffuse Glioma
Perioperative vorasidenib or ivosidenib demonstrated sustained clinical benefit in patients with predominantly non-enhancing IDH1-mutant diffuse glioma.
www.onclive.com
December 4, 2024 at 1:27 PM
oncodaily.bsky.social
6 new drugs in Skin Cancer, Thyroid Cancer, Sarcoma and Glioma by U.S. FDA - Oncology Brothers
@fda.gov
@oncbrothers.bsky.social

oncodaily.com/blog/oncolog...

#AfamiCel #Cancer #Cosibelimab #Glioma #Lifileucel #OncoDaily #Oncology #Sarcoma #Selpercatinib #SkinCancer #FDA #Vorasidenib
Oncology Brothers: 6 new drugs in Skin Cancer, Thyroid Cancer, Sarcoma and Glioma by U.S. FDA - OncoDaily
Oncology Brothers: 6 new drugs in Skin Cancer, Thyroid Cancer, Sarcoma and Glioma by U.S. FDA / AfamiCel, cancer, Cosibelimab, glioma, Lifileucel, OncoDaily,
oncodaily.com
January 1, 2025 at 5:09 PM
cactusdan.bsky.social
And to be clearer the surgery was for the biopsy, they just need to do genetic testing to figure out just what kind of tumor they're dealing with. Fingers crossed for something that responds well to Vorasidenib.
July 22, 2026 at 7:34 AM
braintumourrsch.bsky.social
The MHRA has approved Vorasidenib for certain low-grade gliomas (grade 2 astrocytoma or oligodendroglioma with an IDH1/2 mutation). NICE must now consider whether it will be made available on the NHS.

bit.ly/4grZpmu
MHRA licenses low-grade glioma drug
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved licensing for Vorasidenib. Learn what this means for brain tumour patients here.
bit.ly
September 18, 2025 at 9:21 AM
onclive.bsky.social
Vorasidenib Plus Temozolomide Demonstrates Safety in IDH1/2+ Glioma
@neuroonc.bsky.social #SNO2025 #oncology #braincancer #glioma
www.onclive.com/view/vorasid...
Vorasidenib Plus Temozolomide Demonstrates Safety in IDH1/2+ Glioma | OncLive
Vorasidenib plus temozolomide was safe in glioma harboring IDH1/2 mutations.
www.onclive.com
November 22, 2025 at 1:41 AM
angry-old-goalie.bsky.social
Today was a good day, my daughter received news that her brain cancer has not spread in her quarterly meeting with her Neuro oncologist so we can breathe for three more months.
The total cost of three years of cancer care including vorasidenib has been whatever the parking costs have been.🇨🇦
July 31, 2025 at 10:07 PM
uk-charity.bsky.social
How can the approval of vorasidenib impact brain tumor patients' futures? Let's discuss its significance. #BrainTumorAwareness

https://www.thebraintumourcharity.org/news/charity-news/why-approving-vorasidenib-matters/
Why approving vorasidenib matters
We ve sent your feedback to the consultation on NICE s draft guidance on vorasidenib. These are just some of the powerful testimonies we received that formed part of that.
www.thebraintumourcharity.org
November 5, 2025 at 1:28 PM